Employees Area
Management Profiles

M. Jawed Akhai is a prominent businessman in the pharmaceutical sector. He belongs to a family engaged in pharmaceutical business for over five decades. Currently he holds the position of Chairman at Martin Dow Ltd. Exhibiting inspiring innovativeness and entrepreneurial skills, Jawed Akhai acquired the pharmaceutical manufacturing plant along with the brands of F. Hoffmann-La Roche (Switzerland) in Pakistan and licensing of some of their top line products, which is one of the largest acquisitions in the pharmaceutical industry of Pakistan. Mr. Jawed is a Business Graduate from Institute of Business Administration (IBA). Besides being the Chairman of Martin Dow, he holds many positions with different associations including Former Chairman of Pakistan Pharmaceutical Manufacturer’s Association (PPMA), associate member of FPCCI Trade Body for Pharma Sector, Director of Pakistan-USA business Council of FPCCI, member of Swiss Business Council, member of Pakistan France Business Alliance, member of Karachi Chamber of Commerce & Industry, member of Marketing Association of Pakistan and President of COMMECS (The Old Students Association of Govt. College of Commerce & Economics). At Martin Dow, Jawed is involved in setting the strategic business direction of senior management along with the quest of operational excellence. In addition, Jawed is actively involved in philanthropic activities with the social sector. His main focus is on development of Health & Education segments.

Mr. Mohammad Amjad brings with him vast experience of 35 years in pharmaceutical manufacturing and plant operations with leading companies like Wyeth and Sanofi. Before joining Martin Dow, Mr. Mohammad Amjad served OBS Pakistan as Director Industrial Operations. He holds a Bachelor of Science degree in Industrial Engineering from California State Polytechnic University and MBA from University of La Verne, USA. At Martin Dow, Mr. Mohammad Amjad is leading Technical Operations of Karachi SITE and Seatle – Lahore SITE that includes Production, New Product Development, Regulatory Affairs, Engineering & Projects.

Muqtadir Jawad has been associated with Martin Dow since 2001. With a diversified experience of more than 29 years in the pharmaceutical industry, engaged in matters of supply chain, taxation and corporate affairs, Muqtadir Jawad has gyrated Martin Dow to the level of alacrity. His strong interpersonal skills are an assurance of ascent to newer horizons for the company.

Mr. Ali Aamir brings with him a total of over 30 years of varied experience. He has worked in senior positions with local as well as multinational organizations, adding depth and scale to his knowledge and experience. These include A. F. Ferguson & Co, ANZ Grindlays Bank, ICI Pakistan Limited, Lotte Pakistan PTA Limited, Dawood Hercules Corporation Limited and a brief stint at Herbion Pakistan (Pvt) Limited . Mr. Ali Aamir is a fellow member of the Institute of Chartered Accountants of Pakistan and Associate Member of the Institute of Chartered Accountants in England & Wales. At Martin Dow, Mr. Ali Aamir is looking after the Finance, Information Technology & Commercial functions.

Mr. Rustom J. Boga brings with him a total of over 30 years of comprehensive knowledge and varied experience of marketing and communications. He has been associated with both national and multinational organizations including Unilever, Standard Chartered, Cupola and Manhattan International. He holds a Master of Business Administration (MBA) degree with majors in Marketing from IBA. At Martin Dow, Mr. Rustom J.Boga is responsible for managing all corporate communications of the Group alongside aligning internal communication activities associated with brands activation/promotional campaigns. He is also be responsible for keeping & sustaining relations with both print and electronic media to enhance Group image.

Mr. Asim Mustafa holds Bachelor of Science (Hons) degree from University of Karachi and MBA in Marketing. He is a skilled marketing strategist with extensive experience of both national & international marketing operations. Mr. Asim Mustafa brings with him over 21 years of cumulative experience in strategy & portfolio management working for Aventis Pharma, Abbott Laboratories and Getz Pharma.  He held various key positions at Getz and lastly served there as Director International Business. At Martin Dow, Mr. Asim Mustafa will be leading the Marketing & Sales and International Business functions of the company.

Dr. Farrukh Hafeez has an extensive experience of over 30 years in Pharmaceutical Plant and Quality Operations. He holds a Ph.D. degree in Organic Chemistry from HEJ Research Institute, Karachi. Before becoming a part of Martin Dow, he was affiliated with Abbott Laboratories in the capacity of Director Quality Assurance for over 13 years and was also associated with Searle & Barrett Hodgson on various senior positions. He is the originator of more than 25 research papers which have been published in numerous international journals. Quality Assurance, Quality Control, GMP Compliance and Technical Services of Martin Dow Ltd. – Karachi & Seatle – Lahore sites and overseeing Quality Operations of Meymac & Gien sites will be under his leadership at Martin Dow.

Mr. Ejaz Ahmad holds a Bachelor degree (B.E.) in Mechanical Engineering from NED University of Engineering & Technology, Karachi. He has substantial and extensive experience of over 35 years related to the Engineering functions. Over the course of his career, he remained affiliated on key strategic positions and created value for multinational as well as national pharmaceutical companies including Merck Marker, Hilton Pharma, Pharmatec Pakistan & Abbott Laboratories. All activities associated with Plant Maintenance, Engineering & Projects of Martin Dow Ltd. Karachi and Seatle Lahore are under his leadership and he will also oversee the affairs of engineering functions of Meymac and Gien sites through respective Site Heads.

Dr. Muhammad Raza Zaidi holds Bachelor of Medicine & Bachelor of Surgery degree from University of Sindh and Diploma in TB/Chest Diseases from University of Wales College of Medicine, United Kingdom.He has been associated with multinationals including Glaxo Wellcome Pakistan, Bristol-Myers Squibb as well as Abbott Laboratories, at local as well as Regional levels, on various senior positions in the past. He has in-depth understanding of both local and international market, with extensive experience in Medical & Regulatory Affairs of various countries. Dr. Muhammad Raza Zaidi brings with him more than 26 years of diverse clinical & pharmaceutical experience. Entire Medical Affairs & Compliance functions of Martin Dow Group will be under his leadership.

Mr. Shaikh Muhammad Inam graduated from University of Karachi in 2002 with Bachelor of Pharmacy degree. He brings varied experience of Quality Operations from MNCs including Pfizer, Barret Hodgson and Sanofi. Mr. Inam secured a Gold Medal at Merck Pakistan for his extraordinary services. His area of expertise includes Regulatory matters of local and international market, Global Quality Systems, global and local compliance, audits and training of employees.

Facebook

News & Media

  • Martin Dow supported 9th Tehzeeb Festival & Awards 2018
    Martin Dow supported 9th Tehzeeb Festival & Awards 2018
    (May 24, 2018)

    Read More
  • Martin Dow presents STRINGS live at Habib University
    Martin Dow presents STRINGS live at Habib University
    (May 24, 2018)

    Read More
  • Martin Dow Group hosts the 1st Pakistan Summit 2018
    Martin Dow Group hosts the 1st Pakistan Summit 2018
    (May 24, 2018)

    Read More
  • Martin Dow’s participation in World Economics Forum 2018
    Martin Dow’s participation in World Economics Forum 2018
    (February 6, 2018)

    Read More
  • Martin Dow Health Centre Inauguration Supplement
    Martin Dow Health Centre Inauguration Supplement
    (February 1, 2018)

    Read More
  • Top Pharmaceutical Companies Supplement
    Top Pharmaceutical Companies Supplement
    (October 26, 2017)

    Read More
  • The Swiss Confederation Day Supplement
    The Swiss Confederation Day Supplement
    (October 26, 2017)

    Read More
  • Bastille Day Supplement
    Bastille Day Supplement
    (October 26, 2017)

    Read More
  • Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    (August 3, 2017)

    Read More
  • Martin Dow in talks to buy French biotech firm
    Martin Dow in talks to buy French biotech firm
    (April 12, 2017)

    Read More
  • Martin Dow Pharmaceuticals Inauguration : Meymac France
    Martin Dow Pharmaceuticals Inauguration : Meymac France
    (March 24, 2017)

    Read More
  • World Osteoporosis Day Radio Program
    World Osteoporosis Day Radio Program
    (February 6, 2017)

    Read More
  • Martin Dow-Biocodex to supply Enflor
    Martin Dow-Biocodex to supply Enflor
    (January 18, 2017)

    Read More
  • TerraBiz to hold first M&A moot on December 7
    TerraBiz to hold first M&A moot on December 7
    (January 18, 2017)

    Read More
  • French President to inaugurate Pakistani Pharma Plant in France
    French President to inaugurate Pakistani Pharma Plant in France
    (January 18, 2017)

    Read More
  • Martin Dow acquires Merck operations in Pakistan
    Martin Dow acquires Merck operations in Pakistan
    (January 18, 2017)

    Read More
  • World Mental Health Day
    World Mental Health Day
    (December 22, 2016)

    Read More
  • France Trade & Investment Report 2016
    France Trade & Investment Report 2016
    (July 14, 2016)

    Read More
  • Serving the changing world
    Serving the changing world
    (November 16, 2015)

    Read More
  • Martin Dow setting up clinic for IBA students
    Martin Dow setting up clinic for IBA students
    (November 14, 2015)

    Read More
  • Awarding Dr. Ishrat Hussain
    Awarding Dr. Ishrat Hussain
    (August 31, 2015)

    Read More
  • Martin Dow and quality healthcare go together
    Martin Dow and quality healthcare go together
    (July 14, 2015)

    Read More
  • Martin Dow donates Rs 1 million to IBA
    Martin Dow donates Rs 1 million to IBA
    (April 4, 2015)

    Read More
  • MD Biocodex sign deal
    MD Biocodex sign deal
    (February 26, 2015)

    Read More